I think the management ran the public listed company poorly. If it ran as a private company, it may be OK but the demands for timelines by the sharemarket seem to be too challenging and distracting for this company. I guess the only strategy the company have left is a takeover target once the FDA approval is obtained.
I don't write this off but I'm not holding out any hope for any short term price movements at all.
I think the management ran the public listed company poorly. If...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
